Start with the record
We spend hundreds of hours reading books, papers, primary sources, and archives—then speaking with the people who were there.
Good Pharma is a podcast, created by Deeya Kotecha, exploring the business, science, and human stories behind medicine.
Deeya trained in medicine at Cambridge and worked as a doctor before moving into public markets and venture capital. She writes about biotechnology, the history of drugs, and the business of medicine. More about Deeya →
Behind the medicines are daring founders, accidental discoveries, difficult tradeoffs, and decades-long bets. Good Pharma follows those stories to understand how treatments are discovered, developed, and brought to the people who need them.
“The history of medicine is a history of people deciding what progress should mean.”
GOOD PHARMA · EDITORIAL NOTEThe company that learned how to manufacture hope at industrial scale.
→The rebellion that turned recombinant DNA into an industry.
→The failed heart medicine that became a cultural phenomenon.
→The pill that changed how medicine thinks about risk.
→How a class of medicines changed the language of mental health.
→How a potent toxin became both therapy and cultural shorthand.
→We spend hundreds of hours reading books, papers, primary sources, and archives—then speaking with the people who were there.
The business story matters because incentives determine which ideas get funded, which medicines get developed, how they reach patients, and who can afford them.
Science becomes real in people’s lives. We keep patients, clinicians, researchers, and families at the center of every story.
Eli Lilly begins with an unusual premise: that a pharmaceutical company could be both scientifically ambitious and industrially disciplined. Its history moves through the birth of modern drug manufacturing, the race to produce insulin, and the persistent tension between access, invention, and scale.
This episode follows the people and institutions around those turning points. It asks how a medicine becomes a system—and what changes when a treatment that people cannot live without becomes one of the world’s most valuable products.
This space is reserved for sources, reading notes, timelines, and corrections published alongside the episode.
The transcript will be added here when available.
Good Pharma is designed for an audience interested in science, business, entrepreneurship, and the decisions that shape human health. We work with a small number of thoughtful partners whose work fits that audience.